Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President & CEO

Chief Med and Dev Officer

Chief Operating Officer

Chief Commercial Officer

Chief Scientific Officer

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). It is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. The company was incorporated in 2008 and is headquartered in San Diego, California.

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-18	Premium	gifted	Premium	Premium	Premium	President & CEO
2024-04-15	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-15	Premium	acquired	Premium	Premium	Premium	Chief Med and Dev Officer
2024-04-15	Premium	sold	Premium	Premium	Premium	Chief Med and Dev Officer
2024-04-04	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-04-04	Premium	sold	Premium	Premium	Premium	President & CEO
2024-03-28	Premium	acquired	Premium	Premium	Premium	-
2024-03-28	Premium	sold	Premium	Premium	Premium	-
2024-03-22	Premium	sold	Premium	Premium	Premium	Chief Operating Officer
2024-03-22	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-03-20	Premium	sold	Premium	Premium	Premium	-
2024-03-20	Premium	acquired	Premium	Premium	Premium	Chief Med and Dev Officer
2024-03-20	Premium	acquired	Premium	Premium	Premium	-
2024-03-20	Premium	sold	Premium	Premium	Premium	Chief Med and Dev Officer
2024-03-19	Premium	sold	Premium	Premium	Premium	CFO
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Operating Officer
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	President & CEO
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	CFO
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Med and Dev Officer
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2024-03-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-03-04	Premium	acquired	Premium	Premium	Premium	Chief Operating Officer
2024-03-04	Premium	acquired	Premium	Premium	Premium	President & CEO
2024-03-04	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-04	Premium	acquired	Premium	Premium	Premium	CFO

CRNX - Crinetics Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for CRNX